Page last updated: 2024-08-24

3-iodobenzylguanidine and panobinostat

3-iodobenzylguanidine has been researched along with panobinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bordbar, M; Shahriari, M; Shakibazad, N; Zareifar, S; Zekavat, OR	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and panobinostat

Article	Year
Successful treatment of refractory metastatic neuroblastoma with panobinostat in combination with chemotherapy agents and iodine-131-meta-iodobenzylguanidine therapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:2 Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; Female; Histone Deacetylase Inhibitors; Humans; Iodine Radioisotopes; Neoplasms, Second Primary; Neuroblastoma; Panobinostat; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome	2020

Article

Year

Successful treatment of refractory metastatic neuroblastoma with panobinostat in combination with chemotherapy agents and iodine-131-meta-iodobenzylguanidine therapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:2

Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; Female; Histone Deacetylase Inhibitors; Humans; Iodine Radioisotopes; Neoplasms, Second Primary; Neuroblastoma; Panobinostat; Radiopharmaceuticals; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome

2020